Read + Share
Amedeo Smart
Independent Medical Education
Jones R, Plummer R, Moreno V, Carter L, et al. A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer. Clin Cancer Res 2023;29:331-340.PMID: 36378548
Email
LinkedIn
Facebook
Twitter
Privacy Policy